TherapeuticsMD (TXMD) Change in Inventory (2011 - 2022)
TherapeuticsMD's (TXMD) quarterly Change in Inventory came in at $551000.0 in Q3 2022, up 49.73% YoY from $368000.0 in Q3 2021, and up 119.56% on a QoQ basis from -$2.8 million in Q2 2022.
TherapeuticsMD (TXMD) Change in Inventory (2011 - 2022) Analysis & Trends
TherapeuticsMD (TXMD) has 12 years of Change in Inventory data on file, last reported at $551000.0 in Q3 2022.
- Quarterly Change in Inventory rose 49.73% year-over-year to $551000.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was -$588000.0 (down 2000.0% YoY) and the FY2021 annual result came in at $711000.0, down 78.69% from the prior year.
- Change in Inventory advanced to $551000.0 in Q3 2022, from -$2.8 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $3.0 million in Q3 2019 to a low of -$2.8 million in Q2 2022.
- A 5-year average of $714490.1 and a median of $497644.0 in 2018 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2019 — Change in Inventory surged 1145.66% — and 2022, when it sank 1335.53%.
- Tracing TXMD's Change in Inventory over 5 years: stood at $889449.0 in 2018, then jumped by 49.29% to $1.3 million in 2019, then tumbled by 136.07% to -$479000.0 in 2020, then soared by 154.28% to $260000.0 in 2021, then surged by 111.92% to $551000.0 in 2022.
- The last three Change in Inventory figures came in at $551000.0 (Q3 2022), -$2.8 million (Q2 2022), and $1.4 million (Q1 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.16 Bn | 43.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.86 Bn | 40.20 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 32.53 Bn | 30.86 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.34 Bn | 19.68 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.89 Bn | 18.00 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | TherapeuticsMD | 23.96 Mn | 14.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 551,000.00 |
| Sep 30, 2022 | 551,000.00 |
| Jun 30, 2022 | -2.82 Mn |
| Jun 30, 2022 | -2.82 Mn |
| Mar 31, 2022 | 1.42 Mn |
| Mar 31, 2022 | 1.42 Mn |
| Dec 31, 2021 | 260,000.00 |
| Dec 31, 2021 | 260,000.00 |
| Sep 30, 2021 | 368,000.00 |
| Sep 30, 2021 | 368,000.00 |
| Jun 30, 2021 | 228,000.00 |
| Jun 30, 2021 | 228,000.00 |
| Mar 31, 2021 | -145,000.00 |
| Mar 31, 2021 | -145,000.00 |
| Dec 31, 2020 | -479,000.00 |
| Dec 31, 2020 | -479,000.00 |
| Sep 30, 2020 | -461,000.00 |
| Sep 30, 2020 | -461,000.00 |
| Jun 30, 2020 | 1.39 Mn |
| Jun 30, 2020 | 1.39 Mn |